The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting.

The study hypothesizes that:

• At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program
• Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

Inclusion Criteria:

• Patients with Inflammatory Bowel Disease and self-reported pain
• Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)

Exclusion Criteria:

• Patients that do not report pain
• Anticipated length of hospital stay is less than 72 hours
• Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
• Patients with binocular vision loss
• Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
• Patients that are currently pregnant